Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 11

Results: 19

Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1635, doi. 10.1007/s00262-008-0497-2

By:

Williams, Benjamin B.;
Wall, Meg;
Yu Miao, Rebecca;
Williams, Brenda;
Bertoncello, Ivan;
Kershaw, Michael H.;
Mantamadiotis, Theo;
Haber, Michelle;
Norris, Murray D.;
Gautam, Anand;
Darcy, Phillip K.;
Ramsay, Robert G.

Publication type:

Article

A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1679, doi. 10.1007/s00262-008-0495-4

By:

Berzofsky, Jay A.;
Terabe, Masaki

Publication type:

Article

Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1657, doi. 10.1007/s00262-008-0499-0

By:

Gao, Jian-Qin;
Kanagawa, Naoko;
Dong-Hang Xu;
Min Han;
Sugita, Toshiki;
Hatanaka, Yutaka;
Tani, Yoichi;
Mizuguchi, Hiroyuki;
Tsutsumi, Yasuo;
Mayumi, Tadanori;
Okada, Naoki;
Nakagawa, Shinsaku

Publication type:

Article

Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1625, doi. 10.1007/s00262-008-0496-3

By:

Croce, Michela;
Meazza, Raffaella;
Orengo, Anna M.;
Fabbi, Marina;
Borghi, Martina;
Ribatti, Domenico;
Nico, Beatrice;
Carlini, Barbara;
Pistoia, Vito;
Corrias, Maria Valeria;
Ferrini, Silvano

Publication type:

Article

Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1647, doi. 10.1007/s00262-008-0498-1

By:

Asai, Hirobumi;
Iijima, Hiroko;
Matsunaga, Kenichi;
Oguchi, Yoshiharu;
Katsuno, Hidetoshi;
Maeda, Koutaro

Publication type:

Article

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1579, doi. 10.1007/s00262-008-0505-6

By:

Ménard, Cédric;
Martin, François;
Apetoh, Lionel;
Bouyer, Florence;
Ghiringhelli, François

Publication type:

Article

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1719, doi. 10.1007/s00262-008-0515-4

By:

Seliger, Barbara

Publication type:

Article

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1727, doi. 10.1007/s00262-008-0532-3

By:

Aptsiauri, Natalia;
Carretero, Rafael;
Garcia-Lora, Angel;
Real, Luis M.;
Cabrera, Teresa;
Garrido, Federico

Publication type:

Article

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

Published in:

2008

By:

Stoitzner, Patrizia;
Green, Laura;
Jung, Jae;
Price, Kylie;
Ataera, Haley;
Kivell, Bronwyn;
Ronchese, Franca

Publication type:

Correction Notice

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1705, doi. 10.1007/s00262-008-0561-y

By:

Palma, M.;
Adamson, L.;
Hansson, L.;
Kokhaei, P.;
Rezvany, R.;
Mellstedt, H.;
Österborg, A.;
Choudhury, A.

Publication type:

Article

The “A, B and C” of Her-2 DNA vaccine development.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1711, doi. 10.1007/s00262-008-0464-y

By:

Wei-Zen Wei;
Jacob, Jennifer;
Radkevich-Brown, Olga;
Whittington, Paula M.;
Kong, Yi-chi

Publication type:

Article

Cancer treatment: the combination of vaccination with other therapies.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1735, doi. 10.1007/s00262-008-0480-y

By:

Hald Andersen, Mads;
Bæk Sørensen, Rikke;
Schrama, David;
Svane, Inge Marie;
Becker, Jürgen C.;
thor Straten, Per

Publication type:

Article

Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1685, doi. 10.1007/s00262-008-0481-x

By:

Calogero, Raffaele;
Quaglino, Elena;
Saviozzi, Silvia;
Forni, Guido;
Cavallo, Federica

Publication type:

Article

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1599, doi. 10.1007/s00262-008-0491-8

By:

Bennouna, Jaafar;
Bompas, Emmanuelle;
Neidhardt, Eve Marie;
Rolland, Frédéric;
Philip, Irène;
Galéa, Céline;
Salot, Samuel;
Saiagh, Soraya;
Audrain, Marie;
Rimbert, Marie;
Lafaye-de Micheaux, Sylvie;
Tiollier, Jérôme;
Négrier, Sylvie

Publication type:

Article

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1665, doi. 10.1007/s00262-008-0487-4

By:

Stoitzner, Patrizia;
Green, Laura K.;
Jung, Jae Y.;
Price, Kylie M.;
Atarea, Haley;
Kivell, Bronwyn;
Ronchese, Franca

Publication type:

Article

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1589, doi. 10.1007/s00262-008-0489-2

By:

Boullart, A. C. Inge;
Aarntzen, Erik H. J.;
Verdijk, Pauline;
Jacobs, Joannes F. M.;
Schuurhuis, Danita H.;
Benitez-Ribas, Daniel;
Schreibelt, Gerty;
van de Rakt, Mandy W. M. M.;
Scharenborg, Nicole M.;
de Boer, Annemiek;
Kramer, Matthijs;
Figdor, Carl G.;
Punt, Cornelis J. A.;
Adema, Gosse J.;
de Vries, I. Jolanda M.

Publication type:

Article

Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP–PKA signaling and immunosuppression.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1611, doi. 10.1007/s00262-008-0494-5

By:

Yunyun Su;
Xiaojun Huang;
Raskovalova, Tatiana;
Zacharia, Lefteris;
Lokshin, Anna;
Jackson, Edwin;
Gorelik, Elieser

Publication type:

Article

Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1695, doi. 10.1007/s00262-008-0465-x

By:

Hyun-Il Cho;
Guilian Niu;
Bradley, Norma;
Celis, Esteban

Publication type:

Article

Progress in Vaccination against Cancer 2007 (PIVAC 7).

Published in:: Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1677, doi. 10.1007/s00262-008-0564-8
Publication type:: Article

Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 11

Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer.

A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity.

Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses.

Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.

Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling.

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity.

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors.

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia.

The “A, B and C” of Her-2 DNA vaccine development.

Cancer treatment: the combination of vaccination with other therapies.

Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma.

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E<sub>2</sub> results in high interleukin-12 production and cell migration.

Cooperation of adenosine and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) in amplification of cAMP–PKA signaling and immunosuppression.

Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors.

Progress in Vaccination against Cancer 2007 (PIVAC 7).